Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema

Ophthalmology

Volumn 121, Issue 12, 2014, Pages 2380-2386

  Mesquida, Marina ^a   Molins, Blanca ^b   Llorenç, Victor ^a   Sainz De La Maza, Maite ^a   Adán, Alfredo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; CORTICOSTEROID; CYCLOSPORIN A; DEXAMETHASONE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TOCILIZUMAB; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; BLURRED VISION; CENTRAL FOVEAL THICKNESS; CHORIORETINOPATHY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; CONTINUOUS INFUSION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC PANUVEITIS; IMMUNOSUPPRESSIVE TREATMENT; INDIRECT OPHTHALMOSCOPY; JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS; LONG TERM CARE; MACULAR EDEMA; MEDICAL RECORD REVIEW; MIDDLE AGED; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REFRACTORY UVEITIS RELATED MACULAR EDEMA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SLIT LAMP; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TERTIARY CARE CENTER; TREATMENT RESPONSE; UVEITIS; VISUAL SYSTEM PARAMETERS; YOUNG ADULT; AGED; COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA FOVEA; VISUAL ACUITY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; FOVEA CENTRALIS; HUMANS; INJECTIONS, INTRAVENOUS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; UVEITIS; VISUAL ACUITY; YOUNG ADULT;

EID: 84922164905     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.06.050     Document Type: Article

References (39)

1. C.W. Lardenoye, B. van Kooij, and A. Rothova Impact of macular edema on visual acuity in uveitis Ophthalmology 113 2006 1446 1449
2. M.R. Munk, C.G. Kiss, and I. Steiner Systematic correlation of morphologic alterations and retinal function in eyes with uveitis-associated cystoid macular oedema during development, resolution and relapse Br J Ophthalmol 97 2013 1289 1296
3. M.H. Levin, M. Pistilli, E. Daniel Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema Ophthalmology 121 2014 588 595
4. A. Ossewaarde-van Norel, and A. Rothova Clinical review: update on treatment of inflammatory macular edema Ocul Immunol Inflamm 19 2011 75 83
5. N.N. Markomichelakis, P.G. Theodossiadis, and E. Pantelia Infliximab for chronic cystoid macular edema associated with uveitis Am J Ophthalmol 138 2004 648 650
6. G. Navarro, S. Taroumian, and N. Barroso Tocilizumab in rheumatoid arthritis: a meta-analysis of efficacy and selected clinical conundrums Semin Arthritis Rheum 43 2014 458 469
7. A. Adán, V. Llorenç, M. Mesquida, and L. Pelegrín Tocilizumab treatment for recalcitrant uveitic macular edema Graefes Arch Clin Exp Ophthalmol 251 2013 2249 2250
8. A. Adán, M. Mesquida, and V. Llorenç Tocilizumab treatment for refractory uveitis-related cystoid macular edema Graefes Arch Clin Exp Ophthalmol 251 2013 2627 2632
9. Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop Am J Ophthalmol 140 2005 509 516
10. R.B. Nussenblatt, A.G. Palestine, C.C. Chan, and F. Roberge Standardization of vitreal inflammatory activity in intermediate and posterior uveitis Ophthalmology 92 1985 467 471
11. T. Kishimoto Interleukin-6: from basic science to medicine - 40 years in immunology Annu Rev Immunol 23 2005 1 21
12. H. Nakahara, J. Song, and M. Sugimoto Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis Arthritis Rheum 48 2003 1521 1529
13. P.C. Heinrich, J.V. Castell, and T. Andus Interleukin-6 and the acute phase response Biochem J 265 1990 621 636
14. T. Tanaka, and T. Kishimoto Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases Int J Biol Sci 8 2012 1227 1236
15. M. Fujimoto, S. Serada, and M. Mihara Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses Arthritis Rheum 58 2008 3710 3719
16. B. Liang, D.B. Gardner, and D.E. Griswold Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus Immunology 119 2006 296 305
17. S. Kitaba, H. Murota, and M. Terao Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma Am J Pathol 180 2012 165 176
18. S.J. Brandt, D.M. Bodine, C.E. Dunbar, and A.W. Nienhuis Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice J Clin Invest 86 1990 592 599
19. S. Serada, M. Fujimoto, and M. Mihara IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis Proc Natl Acad Sci U S A 105 2008 9041 9046
20. S. Hohki, N. Ohguro, and H. Haruta Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses Exp Eye Res 91 2010 162 170
21. H. Haruta, N. Ohguro, and M. Fujimoto Blockade of interleukin-6 signaling suppresses not only Th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis Invest Ophthalmol Vis Sci 52 2011 3264 3271
22. V.L. Perez, G.N. Papaliodis, and D. Chu Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts Eye & Ear experience and review of previous studies Ocul Immunol Inflamm 12 2004 193 201
23. S.J. Curnow, F. Falciani, and O.M. Durrani Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis Invest Ophthalmol Vis Sci 46 2005 4251 4259
24. R.R. Caspi, F.G. Roberge, and C.G. McAllister T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat J Immunol 136 1986 928 933
25. A. Amadi-Obi, C.R. Yu, and X. Liu TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 Nat Med 13 2007 711 718
26. E. Bettelli, Y. Carrier, and W. Gao Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
27. T. Yoshimura, K.H. Sonoda, and N. Ohguro Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis Rheumatology (Oxford) 48 2009 347 354
28. R. Alten, and T. Maleitzke Tocilizumab: a novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases Ann Med 45 2013 357 363
29. T. Tanaka Can IL-6 blockade rectify imbalance between Tregs and Th17 cells? Immunotherapy 5 2013 695 697
30. S. Yokota, T. Imagawa, and M. Mori Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial Lancet 371 2008 998 1006
31. N. Nishimoto, Y. Kanakura, and K. Aozasa Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease Blood 106 2005 2627 2632
32. L. Kaly, and I. Rosner Tocilizumab - a novel therapy for non-organ-specific autoimmune diseases Best Pract Res Clin Rheumatol 26 2012 157 165
33. A. Muselier, P. Bielefeld, and S. Bidot Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis Ocul Immunol Inflamm 19 2011 382 383
34. C. Tappeiner, C. Heinz, G. Ganser, and A. Heiligenhaus Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis [letter]? J Rheumatol 39 2012 1294 1295
35. T. Hirano, N. Ohguro, and S. Hohki A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab Mod Rheumatol 22 2012 298 302
36. T. Oshitari, F. Kajita, and A. Tobe Refractory uveitis in patient with Castleman disease successfully treated with tocilizumab Case Rep Ophthalmol Med [serial online] 2012 2012 968180 Available at: http://www.hindawi.com/journals/criopm/2012/968180/ Accessed June 26, 2014
37. M. Shibuya, K. Fujio, and K. Morita Successful treatment with tocilizumab in a case of Cogan's syndrome complicated with aortitis Mod Rheumatol 23 2013 577 581
38. L. Campbell, C. Chen, and S.S. Bhagat Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials Rheumatology (Oxford) 50 2011 552 562
39. M. Mesquida, A. Leszczynska, V. Llorenç, and A. Adán Interleukin-6 blockade in ocular inflammatory diseases Clin Exp Immunol 176 2014 301 309